A different view of thrombosis
The effect of factor X level on thrombin generation and the procoagulant effect of activated factor VII in a cell-based model of coagulation
Models of blood coagulation
Structure of human coagulation activated factor VII
Overall experience with NovoSeven®
Management and monitoring of recombinant activated factor VII
Experience with continuous infusion of recombinant activated factor VII in the Asia-Pacific region
Treatment of bleeding episodes in patients with hemophilia and an inhibitor: comparison of two treatment protocols with recombinant activated factor VII
NovoSeven® in immune tolerance therapy
Acute hemarthroses: the benefits of early versus late treatment with recombinant activated factor VII
Patient/caregiver assessment of convenience in the use of recombinant activated factor VII (rVIIa; NovoSeven®) in home therapy
Platelet physiology and function
Recombinant activated factor VII (NovoSeven®) treatment of platelet-related bleeding disorders
Coagulation problems in liver disease
Clinical aspects of bleeding complications in cirrhotic patients
Bleeding problems in patients undergoing segmental liver transplantation
Blood loss in orthotopic liver transplantation: a retrospective analysis of transfusion requirements and the effects of autotransfusion of cell saver blood in 164 consecutive patients
Measurement of the procoagulant activity of factor VII in patients with liver cirrhosis and normal prothrombin activity: evaluation of the bleeding risk
Recombinant activated factor VII in children with acute bleeding resulting from liver failure and disseminated intravascular coagulation
NovoSeven® as a universal haemostatic agent
NovoSeven® in warfarin-treated patients
Potential role of NovoSeven® in the prevention of rebleeding following aneurysmal subarachnoid haemorrhage
Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven®) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery
The effect of the administration of recombinant activated factor VII (NovoSeven®) on perioperative blood loss in patients undergoing transabdominal retropubic prostatectomy: the PROSE study
Influence of activated factor VII concentrates on thrombin generation in full-term and preterm neonates
Active site-blocked activated factor VII as an effective antithrombotic agent: mechanism of action
Effect of locally-applied active site-blocked activated factor VII (ASIS) on experimental arterial thrombosis
Effects of recombinant active site-blocked activated factor VII in rabbit models of carotid stenosis and myocardial infarction
Comparison of the factor VII:C clot analysis and a modified activated factor VII analysis for monitoring factor VII activity in patients treated with recombinant activated factor VII (NovoSeven®)